Are you at risk of schizophrenia? Brain activity pattern may have an answer

BOSTON: Scientists have identified a pattern of brain activity that predicts the development of schizophrenia, an advance that could be used to diagnose the disorder earlier.

Schizophrenia, a brain disorder that produces hallucinations, delusions, and cognitive impairments, usually strikes during adolescence or young adulthood.

While some signs can suggest that a person is at high risk for developing the disorder, there is no way to definitively diagnose it until the first psychotic episode occurs.

“If we use these types of brain measurements, then maybe we can predict a little bit better who will end up developing psychosis, and that may also help tailor interventions,” said Guusje Collin, a visiting scientist at Massachusetts Institute of Technology in the US.

Before they experience a psychotic episode, characterised by sudden changes in behaviour and a loss of touch with reality, patients can experience milder symptoms such as disordered thinking.

This kind of thinking can lead to behaviours such as jumping from topic to topic at random, or giving answers unrelated to the original question. Previous studies have shown that about 25 percent of people who experience these early symptoms go on to develop schizophrenia.

The researchers followed 158 people between the ages of 13 and 34 who were identified as high-risk because they had experienced early symptoms.

The team also included 93 control subjects, who did not have any risk factors. At the beginning of the study, the researchers used functional magnetic resonance imaging (fMRI) to measure a type of brain activity involving “resting state networks.”

Resting state networks consist of brain regions that preferentially connect with and communicate with each other when the brain is not performing any particular cognitive task.

“We were interested in looking at the intrinsic functional architecture of the brain to see if we could detect early aberrant brain connectivity or networks in individuals who are in the clinically high-risk phase of the disorder,” said Susan Whitfield-Gabrieli, a visiting scientist at MIT.

One year after the initial scans, 23 of the high-risk patients had experienced a psychotic episode and were diagnosed with schizophrenia.

In those patients’ scans, taken before their diagnosis, the researchers found a distinctive pattern of activity that was different from the healthy control subjects and the at-risk subjects who had not developed psychosis.

  • Related Posts

    Chandigarh News: Dibar Pharmaceutical Company Misled PGI Through Fake Letter, Case Registered – Dibar Pharmaceutical Company Misled PGI Through Fake Letter, Case Registered

    Chandigarh:  A case has been registered against a pharmaceutical company for trying to mislead PGI by creating a fake letter from CDSCO (Central Drugs Standard Control Organisation) Baddi to prove…

    Kushinagar News: Truck Was Traveling From Ghaziabad To Agartala, Mystery Revealed When It Overturned

    Case of codeine syrup being hidden among sugar sacks in a truck. After receiving the documents, the pharmaceutical department sent them to Ghaziabad and Agartala and started investigation. Kushinagar/Rahsu Bazaar.…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    ACB Gujarat Nabs Female Drug Inspector In A Bribe Case

    ACB Gujarat Nabs Female Drug Inspector In A Bribe Case

    Netherlands: Health Secy Visits Bilthoven Biologicals, Discusses Collaboration On Production Of Oral Polio Vaccine

    Netherlands: Health Secy Visits Bilthoven Biologicals, Discusses Collaboration On Production Of Oral Polio Vaccine

    India Lifts Safeguard Measures On Isopropyl Alcohol Imports

    India Lifts Safeguard Measures On Isopropyl Alcohol Imports

    Punjab And Haryana HC Notice To Centre On Petition Against Misuse Of Oxytocin

    Punjab And Haryana HC Notice To Centre On Petition Against Misuse Of Oxytocin

    Nepal Drugs Regulator To Conduct On-Site Testing Of Medicines

    Nepal Drugs Regulator To Conduct On-Site Testing Of Medicines

    ‘Auric’ Relied On Amazon Reviews For Research Claims To Cure Fatty Liver

    ‘Auric’ Relied On Amazon Reviews For Research Claims To Cure Fatty Liver